POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	2hi9	PLASMA SERINE PROTEASE INHIBITOR (Homo sapiens)	5 / 12	VAL A 334 ILE A 289 ILE A 184 PHE A 372 ILE A 249	None	1.07A	22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	3mos	TRANSKETOLASE (Homo sapiens)	5 / 12	GLY A 569 VAL A 572 ILE A 537 LEU A 532 ILE A 529	None	1.02A	20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	3rip	GAMMA-TUBULIN COMPLEX COMPONENT 4 (Homo sapiens)	5 / 12	ILE A 613 LEU A 595 PHE A 592 LEU A 588 ILE A 512	None	1.02A	20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	3v4y	NUCLEAR INHIBITOR OF PROTEIN PHOSPHATASE 1 SERINE/THREONINE-PRO TEIN PHOSPHATASE PP1-ALPHA CATALYTIC SUBUNIT (Homo sapiens)	5 / 12	GLY A  67 ILE A  65 TYR A  70 LEU A  73 ILE B 210	None	1.04A	20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	3zdu	CYCLIN-DEPENDENT KINASE-LIKE 3 (Homo sapiens)	5 / 12	GLY A 188 ILE A 262 LEU A 110 PHE A 107 ILE A 292	None	1.03A	23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	4fm9	DNA TOPOISOMERASE 2-ALPHA (Homo sapiens)	5 / 12	PHE A 569 GLY A 534 ILE A 536 LEU A 516 ILE A 507	None	1.07A	18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	4npk	EXTENDED SYNAPTOTAGMIN-2 (Homo sapiens)	5 / 12	PHE A 391 GLY A 416 ILE A 418 LEU A 499 PHE A 489	None	0.96A	18.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	4p42	EXTENDED SYNAPTOTAGMIN-2 (Homo sapiens)	5 / 12	PHE A 363 GLY A 388 ILE A 390 LEU A 471 PHE A 461	None	0.95A	21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	4yep	LAMININ SUBUNIT ALPHA-2 (Homo sapiens)	5 / 12	GLY A1278 ILE A1276 PHE A1241 MET A1359 ILE A1357	None None None None EDO  A1409 ( 2.5A)	1.05A	19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	4yeq	LAMININ SUBUNIT ALPHA-2 (Homo sapiens)	5 / 12	GLY U 103 ILE U 101 PHE U  66 MET U 184 ILE U 182	None	0.98A	18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	5gwj	DNA TOPOISOMERASE 2-BETA (Homo sapiens)	5 / 12	PHE A 585 GLY A 550 ILE A 552 LEU A 532 ILE A 523	None	0.99A	19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	5o1p	ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE, MITOCHONDRIAL (Homo sapiens)	5 / 12	ILE A 903 ILE A 911 PRO A 877 LEU A 601 ILE A 579	None	0.97A	21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD4_C_AOQC4003_1 (CYTOCHROME B)	6bq1	PHOSPHATIDYLINOSITOL 4-KINASE III ALPHA (PI4KA) (Homo sapiens)	5 / 12	PHE A1872 GLY A2023 ILE A2074 LEU A1949 ILE A1972	None	0.84A	0.00